BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

349 related articles for article (PubMed ID: 20145124)

  • 1. NOTCH signaling is required for formation and self-renewal of tumor-initiating cells and for repression of secretory cell differentiation in colon cancer.
    Sikandar SS; Pate KT; Anderson S; Dizon D; Edwards RA; Waterman ML; Lipkin SM
    Cancer Res; 2010 Feb; 70(4):1469-78. PubMed ID: 20145124
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NOTCH Signaling Regulates Asymmetric Cell Fate of Fast- and Slow-Cycling Colon Cancer-Initiating Cells.
    Srinivasan T; Walters J; Bu P; Than EB; Tung KL; Chen KY; Panarelli N; Milsom J; Augenlicht L; Lipkin SM; Shen X
    Cancer Res; 2016 Jun; 76(11):3411-21. PubMed ID: 27197180
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The class I HDAC inhibitor MGCD0103 induces cell cycle arrest and apoptosis in colon cancer initiating cells by upregulating Dickkopf-1 and non-canonical Wnt signaling.
    Sikandar S; Dizon D; Shen X; Li Z; Besterman J; Lipkin SM
    Oncotarget; 2010 Nov; 1(7):596-605. PubMed ID: 21317455
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prostaglandin E2 Promotes Colorectal Cancer Stem Cell Expansion and Metastasis in Mice.
    Wang D; Fu L; Sun H; Guo L; DuBois RN
    Gastroenterology; 2015 Dec; 149(7):1884-1895.e4. PubMed ID: 26261008
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The miR-371∼373 Cluster Represses Colon Cancer Initiation and Metastatic Colonization by Inhibiting the TGFBR2/ID1 Signaling Axis.
    Ullmann P; Rodriguez F; Schmitz M; Meurer SK; Qureshi-Baig K; Felten P; Ginolhac A; Antunes L; Frasquilho S; Zügel N; Weiskirchen R; Haan S; Letellier E
    Cancer Res; 2018 Jul; 78(14):3793-3808. PubMed ID: 29748374
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HES1-mediated inhibition of Notch1 signaling by a Gemini vitamin D analog leads to decreased CD44(+)/CD24(-/low) tumor-initiating subpopulation in basal-like breast cancer.
    So JY; Wahler J; Das Gupta S; Salerno DM; Maehr H; Uskokovic M; Suh N
    J Steroid Biochem Mol Biol; 2015 Apr; 148():111-21. PubMed ID: 25541438
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MET signaling in colon cancer stem-like cells blunts the therapeutic response to EGFR inhibitors.
    Luraghi P; Reato G; Cipriano E; Sassi F; Orzan F; Bigatto V; De Bacco F; Menietti E; Han M; Rideout WM; Perera T; Bertotti A; Trusolino L; Comoglio PM; Boccaccio C
    Cancer Res; 2014 Mar; 74(6):1857-69. PubMed ID: 24448239
    [TBL] [Abstract][Full Text] [Related]  

  • 8. STAT3 is necessary for proliferation and survival in colon cancer-initiating cells.
    Lin L; Liu A; Peng Z; Lin HJ; Li PK; Li C; Lin J
    Cancer Res; 2011 Dec; 71(23):7226-37. PubMed ID: 21900397
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Atonal homolog 1 is required for growth and differentiation effects of notch/gamma-secretase inhibitors on normal and cancerous intestinal epithelial cells.
    Kazanjian A; Noah T; Brown D; Burkart J; Shroyer NF
    Gastroenterology; 2010 Sep; 139(3):918-28, 928.e1-6. PubMed ID: 20621629
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Portulaca oleracea extract can inhibit nodule formation of colon cancer stem cells by regulating gene expression of the Notch signal transduction pathway.
    Jin H; Chen L; Wang S; Chao D
    Tumour Biol; 2017 Jul; 39(7):1010428317708699. PubMed ID: 28714363
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dclk1, a tumor stem cell marker, regulates pro-survival signaling and self-renewal of intestinal tumor cells.
    Chandrakesan P; Yao J; Qu D; May R; Weygant N; Ge Y; Ali N; Sureban SM; Gude M; Vega K; Bannerman-Menson E; Xia L; Bronze M; An G; Houchen CW
    Mol Cancer; 2017 Feb; 16(1):30. PubMed ID: 28148261
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fusobacterium nucleatum Increases Proliferation of Colorectal Cancer Cells and Tumor Development in Mice by Activating Toll-Like Receptor 4 Signaling to Nuclear Factor-κB, and Up-regulating Expression of MicroRNA-21.
    Yang Y; Weng W; Peng J; Hong L; Yang L; Toiyama Y; Gao R; Liu M; Yin M; Pan C; Li H; Guo B; Zhu Q; Wei Q; Moyer MP; Wang P; Cai S; Goel A; Qin H; Ma Y
    Gastroenterology; 2017 Mar; 152(4):851-866.e24. PubMed ID: 27876571
    [TBL] [Abstract][Full Text] [Related]  

  • 13. FOXM1-Induced PRX3 Regulates Stemness and Survival of Colon Cancer Cells via Maintenance of Mitochondrial Function.
    Song IS; Jeong YJ; Jeong SH; Heo HJ; Kim HK; Bae KB; Park YH; Kim SU; Kim JM; Kim N; Ko KS; Rhee BD; Han J
    Gastroenterology; 2015 Oct; 149(4):1006-16.e9. PubMed ID: 26091938
    [TBL] [Abstract][Full Text] [Related]  

  • 14. KIT Signaling Promotes Growth of Colon Xenograft Tumors in Mice and Is Up-Regulated in a Subset of Human Colon Cancers.
    Chen EC; Karl TA; Kalisky T; Gupta SK; O'Brien CA; Longacre TA; van de Rijn M; Quake SR; Clarke MF; Rothenberg ME
    Gastroenterology; 2015 Sep; 149(3):705-17.e2. PubMed ID: 26026391
    [TBL] [Abstract][Full Text] [Related]  

  • 15. EGFR/Notch Antagonists Enhance the Response to Inhibitors of the PI3K-Akt Pathway by Decreasing Tumor-Initiating Cell Frequency.
    Fu W; Lei C; Yu Y; Liu S; Li T; Lin F; Fan X; Shen Y; Ding M; Tang Y; Ye X; Yang Y; Hu S
    Clin Cancer Res; 2019 May; 25(9):2835-2847. PubMed ID: 30670492
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Suppression of renal cell carcinoma growth by inhibition of Notch signaling in vitro and in vivo.
    Sjölund J; Johansson M; Manna S; Norin C; Pietras A; Beckman S; Nilsson E; Ljungberg B; Axelson H
    J Clin Invest; 2008 Jan; 118(1):217-28. PubMed ID: 18079963
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ID1 and ID3 regulate the self-renewal capacity of human colon cancer-initiating cells through p21.
    O'Brien CA; Kreso A; Ryan P; Hermans KG; Gibson L; Wang Y; Tsatsanis A; Gallinger S; Dick JE
    Cancer Cell; 2012 Jun; 21(6):777-92. PubMed ID: 22698403
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Loss of Mel-18 enhances breast cancer stem cell activity and tumorigenicity through activating Notch signaling mediated by the Wnt/TCF pathway.
    Won HY; Lee JY; Shin DH; Park JH; Nam JS; Kim HC; Kong G
    FASEB J; 2012 Dec; 26(12):5002-13. PubMed ID: 22954590
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Notch Inhibitor PF-03084014 Inhibits Hepatocellular Carcinoma Growth and Metastasis via Suppression of Cancer Stemness due to Reduced Activation of Notch1-Stat3.
    Wu CX; Xu A; Zhang CC; Olson P; Chen L; Lee TK; Cheung TT; Lo CM; Wang XQ
    Mol Cancer Ther; 2017 Aug; 16(8):1531-1543. PubMed ID: 28522590
    [TBL] [Abstract][Full Text] [Related]  

  • 20. FGF Signalling in the Self-Renewal of Colon Cancer Organoids.
    Otte J; Dizdar L; Behrens B; Goering W; Knoefel WT; Wruck W; Stoecklein NH; Adjaye J
    Sci Rep; 2019 Nov; 9(1):17365. PubMed ID: 31758153
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.